Cantor Fitzgerald’s Post

View organization page for Cantor Fitzgerald, graphic

113,116 followers

Companies that develop treatments for rare diseases are able to drive real value, despite a prior view that they were low market opportunities. Our research analyst, Kristen Kluska, unpacks how our research team uncovers the true impact of these companies. #CantorCalls #MarketResearch #RareDiseases

Bina Maniar

Founder & CEO, Project 8p Foundation | Investor | Consultant

1mo

Thank you Cantor for bringing this to the main stage. Over 10,000 rare diseases+...collectively and individually are not so rare anymore with the advancements of genetic testing.

Carvey Leung

Equity Research Associate at Cantor Fitzgerald

1mo

Awesome, thanks for bringing rare diseases to the masses!

Gabrielle (Gabie) Ingoglia

Equity Research Associate at Cantor Fitzgerald

1mo

Kristen Kluska amazing!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics